title: Recommendations for the therapeutics of methotrexate in rheumatoid arthritis.
authors.forename: G
authors.initials: G
authors.lastname: Murphy
authors.forename: R
authors.initials: R
authors.lastname: Coughlan
authors.forename: J
authors.initials: J
authors.lastname: Devlin
authors.forename: O
authors.initials: O
authors.lastname: FitzGerald
authors.forename: G
authors.initials: G
authors.lastname: McCarthy
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D001691:Biological Therapy; D004359:Drug Therapy, Combination; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use*; D019990:Perioperative Care
chemical_list: D018501:Antirheumatic Agents; D007166:Immunosuppressive Agents; D008727:Methotrexate